Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia (ADVANCE)
Public ClinicalTrials.gov record NCT02970305. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia
Study identification
- NCT ID
- NCT02970305
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- ACADIA Pharmaceuticals Inc.
- Industry
- Enrollment
- 403 participants
Conditions and interventions
Conditions
Interventions
- Pimavanserin Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 55 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 3, 2016
- Primary completion
- Oct 15, 2019
- Completion
- Oct 27, 2019
- Last update posted
- Dec 21, 2020
2016 – 2019
United States locations
- U.S. sites
- 33
- U.S. states
- 17
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Phoenix | Arizona | 85012 | — |
| Not listed | Rogers | Arkansas | 72758 | — |
| Not listed | Bellflower | California | 90706 | — |
| Not listed | Lemon Grove | California | 91945 | — |
| Not listed | Norwalk | California | 90650 | — |
| Not listed | San Diego | California | 92103 | — |
| Not listed | San Diego | California | 92123 | — |
| Not listed | Santa Ana | California | 92705 | — |
| Not listed | Torrance | California | 90502 | — |
| Not listed | Hialeah | Florida | 33016 | — |
| Not listed | Lauderhill | Florida | 33319 | — |
| Not listed | Miami | Florida | 33122 | — |
| Not listed | Miami | Florida | 33136 | — |
| Not listed | Tampa | Florida | 33613 | — |
| Not listed | Atlanta | Georgia | 30328 | — |
| Not listed | Atlanta | Georgia | 30331 | — |
| Not listed | Decatur | Georgia | 30030 | — |
| Not listed | Marietta | Georgia | 30060 | — |
| Not listed | Chicago | Illinois | 60611 | — |
| Not listed | Hoffman Estates | Illinois | 60169 | — |
| Not listed | Wichita | Kansas | 67214 | — |
| Not listed | Ann Arbor | Michigan | 48105 | — |
| Not listed | Las Vegas | Nevada | 89102 | — |
| Not listed | Berlin | New Jersey | 08009 | — |
| Not listed | Albuquerque | New Mexico | 87109 | — |
| Not listed | Rochester | New York | 14618 | — |
| Not listed | Charlotte | North Carolina | 28211 | — |
| Not listed | Durham | North Carolina | 27704 | — |
| Not listed | Oklahoma City | Oklahoma | 73116 | — |
| Not listed | Downingtown | Pennsylvania | 19335 | — |
| Not listed | Charleston | South Carolina | 29407 | — |
| Not listed | Irving | Texas | 75062 | — |
| Not listed | Richardson | Texas | 75080 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 68 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02970305, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 21, 2020 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02970305 live on ClinicalTrials.gov.